1Elston CW, Sloane JP, Amendoeira I, et al. Causes of inconsistency in diagnosing and classifying intraductal proliferations of the breast. European Commission Working Group on Breast Screening Pathology[J] . Eur J Cancer,2000,36(14): 1769-1772.
2Parkin DM. Global cancer statistics in the year 2000[J].Lancet Oncol, 2001,2(9):533-543.
3Schena M, Shalon D, Davis RW, et al. Quantitative monitoring of gene expression patterns with a complementary DNA microarray[J]. Science, 1995, 270(5235):467-470.
4DeRisi J, Penland L, Brown PO, et al. Use of a cDNA microarray to analyse gene expression patterns in human cancer[J]. Nat Genet, 1996,14(4):457-460.
5Golub TR, Slonim DK, Tamayo P, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring[J]. Science, 1999, 286(5439):531-537.
6Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling[J]. Nature, 2000,403(6769):503-511.
7Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours[J]. Nature, 2000,406(6797):747-752.
8van't Veer LJ, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer[J]. Nature, 2002,415(6871):530-536.
9Weigelt B, Glas AM, Wessels LF, et al. Gene expression profiles of primary breast tumors maintained in distant metastases[J]. Proc Natl AcadSci U S A, 2003,100(26):15901-15905.
10Ramaswamy S, Ross KN, Lander ES, et al. A molecular signature of metastasis in primary solid tumors[J] . Nat Genet, 2003,33(1):49-54.
